Regeneron Pharmaceuticals, Inc.

( )
REGN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 3.28%61.090.0%$918.14m
NVAXNovavax, Inc. 31.62%104.56102.0%$825.80m
AMGNAmgen, Inc. -1.21%253.151.3%$733.54m
REGNRegeneron Pharmaceuticals, Inc. 2.17%640.882.5%$687.80m
GILDGilead Sciences, Inc. -0.44%76.421.0%$676.56m
BIIBBiogen, Inc. -0.54%268.351.6%$573.84m
VRTXVertex Pharmaceuticals, Inc. 2.66%299.061.9%$522.97m
ILMNIllumina, Inc. -1.92%372.123.5%$297.26m
ALXNAlexion Pharmaceuticals, Inc. -0.98%112.462.0%$230.21m
BMRNBioMarin Pharmaceutical, Inc. 0.21%127.984.3%$212.65m
SGENSeattle Genetics, Inc. 3.34%176.146.1%$207.80m
SRNESorrento Therapeutics, Inc. 3.00%7.381.8%$195.17m
IMMUImmunomedics, Inc. 1.30%41.1611.0%$178.10m
SRPTSarepta Therapeutics, Inc. 0.25%163.8913.9%$167.23m
INCYIncyte Corp. 0.80%108.652.5%$166.01m

Company Profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.